Christopher Thibodeau

Christopher brings 25 years of successful commercial operations experience, principally in molecular diagnostics and oncology. Prior to joining OncoCell MDx, he served as Chief Operating Officer for MDxHealth, a publicly traded multi-national molecular diagnostics company that specializes in epigenetic testing solutions for urologic oncology. Christopher was instrumental in the company’s growth, establishing US Operations and leading the team initiatives that successfully delivered validation, guideline inclusion, reimbursement and market adoption of the company’s products and services. Previously, Christopher held various leadership positions at Agendia, Numira Biosciences, US LABS (acquired by LabCorp) and Ventana Medical Systems (acquired by Roche).